Source: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?cfrpart=310&amp;showfr=1
Timestamp: 2019-04-23 02:20:07+00:00

Document:
§ 310.3 - Definitions and interpretations.
§ 310.4 - Biologics; products subject to license control.
§ 310.6 - Applicability of "new drug" or safety or effectiveness findings in drug efficacy study implementation notices and notices of opportunity for hearing to identical, related, and similar drug products.
§ 310.100 - New drug status opinions; statement of policy.
§ 310.103 - New drug substances intended for hypersensitivity testing.
§ 310.200 - Prescription-exemption procedure.
§ 310.201 - Exemption for certain drugs limited by new-drug applications to prescription sale.
§ 310.303 - Continuation of long-term studies, records, and reports on certain drugs for which new drug applications have been approved.
§ 310.305 - Records and reports concerning adverse drug experiences on marketed prescription drugs for human use without approved new drug applications.
§ 310.306 - Notification of a permanent discontinuance or an interruption in manufacturing of marketed prescription drugs for human use without approved new drug applications.
§ 310.501 - Patient package inserts for oral contraceptives.
§ 310.502 - Certain drugs accorded new drug status through rulemaking procedures.
§ 310.503 - Requirements regarding certain radioactive drugs.
§ 310.509 - Parenteral drug products in plastic containers.
§ 310.515 - Patient package inserts for estrogens.
§ 310.517 - Labeling for oral hypoglycemic drugs of the sulfonylurea class.
§ 310.518 - Drug products containing iron or iron salts.
§ 310.519 - Drug products marketed as over-the-counter (OTC) daytime sedatives.
§ 310.527 - Drug products containing active ingredients offered over-the-counter (OTC) for external use as hair growers or for hair loss prevention.
§ 310.528 - Drug products containing active ingredients offered over-the-counter (OTC) for use as an aphrodisiac.
§ 310.529 - Drug products containing active ingredients offered over-the-counter (OTC) for oral use as insect repellents.
§ 310.530 - Topically applied hormone-containing drug products for over-the-counter (OTC) human use.
§ 310.531 - Drug products containing active ingredients offered over-the-counter (OTC) for the treatment of boils.
§ 310.532 - Drug products containing active ingredients offered over-the-counter (OTC) to relieve the symptoms of benign prostatic hypertrophy.
§ 310.533 - Drug products containing active ingredients offered over-the-counter (OTC) for human use as an anticholinergic in cough-cold drug products.
§ 310.534 - Drug products containing active ingredients offered over-the-counter (OTC) for human use as oral wound healing agents.
§ 310.536 - Drug products containing active ingredients offered over-the-counter (OTC) for use as a nailbiting or thumbsucking deterrent.
§ 310.537 - Drug products containing active ingredients offered over-the-counter (OTC) for oral administration for the treatment of fever blisters and cold sores.
§ 310.538 - Drug products containing active ingredients offered over-the-counter (OTC) for use for ingrown toenail relief.
§ 310.540 - Drug products containing active ingredients offered over-the-counter (OTC) for use as stomach acidifiers.
§ 310.541 - Over-the-counter (OTC) drug products containing active ingredients offered for use in the treatment of hypophosphatemia.
§ 310.542 - Over-the-counter (OTC) drug products containing active ingredients offered for use in the treatment of hyperphosphatemia.
§ 310.543 - Drug products containing active ingredients offered over-the-counter (OTC) for human use in exocrine pancreatic insufficiency.
§ 310.544 - Drug products containing active ingredients offered over-the-counter (OTC) for use as a smoking deterrent.
§ 310.545 - Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses.
§ 310.546 - Drug products containing active ingredients offered over-the-counter (OTC) for the treatment and/or prevention of nocturnal leg muscle cramps.
§ 310.547 - Drug products containing quinine offered over-the-counter (OTC) for the treatment and/or prevention of malaria.
§ 310.548 - Drug products containing colloidal silver ingredients or silver salts offered over-the-counter (OTC) for the treatment and/or prevention of disease.

References: § 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310

§ 310